Cargando…
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
BACKGROUND: Musashi-2 (MSI2) is a member of RNA-binding protein family that regulates mRNA translation of numerous intracellular targets and influences maintenance of stem cell identity. This study assessed MSI2 as a potential clinical biomarker in non-small cell lung cancer (NSCLC). METHODS: The cu...
Autores principales: | Topchu, Iuliia, Karnaukhov, Nikolai, Mazitova, Alexandra, Yugai, Veronika, Voloshin, Mark, Tikhomirova, Mariya, Kit, Oleg, Frantsiyants, Elena, Kharin, Leonid, Airapetova, Tamara, Ratner, Ekaterina, Sabirov, Alexey, Abramova, Zinaida, Serebriiskii, Iliya, Boumber, Yanis, Deneka, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024834/ https://www.ncbi.nlm.nih.gov/pubmed/33841930 http://dx.doi.org/10.21037/jtd-20-2787 |
Ejemplares similares
-
NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression
por: Tikhomirova, Mariya, et al.
Publicado: (2022) -
Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression
por: Kharin, Leonid, et al.
Publicado: (2021) -
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021) -
Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer
por: Bychkov, Igor, et al.
Publicado: (2023) -
Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer
por: Bychkov, Igor, et al.
Publicado: (2023)